Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: a True Effect or a Bias? A Systematic Review & Meta-Analysis

被引:24
|
作者
Leshem, Regina [1 ]
Bar-Oz, Benjamin [2 ]
Diav-Citrin, Orna [1 ,3 ]
Gbaly, Siham [1 ]
Soliman, Jessica [1 ]
Renoux, Christel [4 ]
Matok, Ilan [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Ein Kerem Campus, Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Minist Hlth, Israeli Teratol Informat Serv, Jerusalem, Israel
[4] McGill Univ, Montreal, PQ, Canada
关键词
SSRI's; SNRI's; antidepressants; ASD; ADHD; prenatal exposure; pregnancy; MATERNAL ANTIDEPRESSANT USE; PLACENTAL-TRANSFER; PRETERM BIRTH; FUNNEL-PLOT; DEPRESSION; EXPOSURE; OUTCOMES;
D O I
10.2174/1570159X19666210303121059
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background and objective: An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to study this association and to look for sources of bias by performing a systematic review and meta-analysis. Methods: Medline, Embase, and the Cochrane Library were searched up to June 2019 for studies reporting on ASD and ADHD in the Offspring following exposure during pregnancy. We followed the PRISMA 2009 guidelines for data selection and extraction. Outcomes were pooled using random-effects models and odds ratios (OR), and 95% confidence intervals (CI) were calculated for each outcome using the adjusted point estimate of each study. Results: Eighteen studies were included in the meta-analysis. We found an association between SSRIs/SNRIs prenatal use and the risk for ASD and ADHD (OR=1.42, 95% CI: 1.23-1.65, I-2=58%; OR=1.26, 95% CI: 1.07-1.49, I-2=48%, respectively). Similar findings were obtained in women who were exposed to SSRIs/SNRIs before pregnancy, representing statistically significant association with ASD (OR=1.39, 95% CI: 1.24-1.56, I-2=33%) and ADHD (OR=1.63, 95% CI: 1.50-1.78, I-2=0%) in the Offspring, although they were not exposed to those medications in utero. Conclusions: Although we found an association between exposure to SSRIs/SNRIs during pregnancy and the risk for ASD and ADHD, an association with those disorders was also present for exposure pre-pregnancy, suggesting that the association might be due to unmeasured confounding. We are aiming to further assess the role of potential unmeasured confounding in the estimation of the association and perform a network meta-analysis.
引用
收藏
页码:896 / 906
页数:11
相关论文
共 50 条
  • [1] Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review
    Le, Gia Han
    Wong, Sabrina
    Lu, Andy
    Vasudeva, Shreya
    Gill, Hartej
    Badulescu, Sebastian
    Portelles, Daylen Rodriguez
    Zheng, Yang Jing
    Teopiz, Kayla M.
    Meshkat, Shakila
    Kwan, Angela T. H.
    Ho, Roger
    Rhee, Taeho Greg
    Rosenblat, Joshua D.
    Mansur, Rodrigo B.
    McIntyre, Roger S.
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 368 : 798 - 819
  • [2] Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis
    Kobayashi, Tohru
    Matsuyama, Tasuku
    Takeuchi, Masanobu
    Ito, Shinya
    REPRODUCTIVE TOXICOLOGY, 2016, 65 : 170 - 178
  • [3] Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies
    Man, Kenneth K. C.
    Tong, Henry H. Y.
    Wong, Lisa Y. L.
    Chan, Esther W.
    Simonoff, Emily
    Wong, Ian C. K.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2015, 49 : 82 - 89
  • [4] IN UTERO EXPOSURE TO SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND RISK FOR AUTISM SPECTRUM DISORDERS (ASD).
    Gidaya, N. B.
    Lee, B. K.
    Burstyn, I.
    Heavner, K.
    Michael, Y. L.
    Yudell, M.
    Mortensen, E. L.
    Newschaffer, C. J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S127 - S127
  • [5] Use of Serotonin Norepinephrine Reuptake Inhibitors in the Treatment of Attention-Deficit Hyperactivity Disorder in Pediatrics
    Park, Pauline
    Caballero, Joshua
    Omidian, Hossein
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (01) : 86 - 92
  • [6] Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review
    Nanjappa, Muralidhara Shankarapura
    Voyiaziakis, Emanuel
    Pradhan, Basant
    Thippaiah, Srinagesh Mannekote
    CNS SPECTRUMS, 2022, 27 (03) : 290 - 297
  • [7] In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
    Gidaya, Nicole B.
    Lee, Brian K.
    Burstyn, Igor
    Yudell, Michael
    Mortensen, Erik L.
    Newschaffer, Craig J.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2014, 44 (10) : 2558 - 2567
  • [8] In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
    Nicole B. Gidaya
    Brian K. Lee
    Igor Burstyn
    Michael Yudell
    Erik L. Mortensen
    Craig J. Newschaffer
    Journal of Autism and Developmental Disorders, 2014, 44 : 2558 - 2567
  • [9] Combined Methylphenidate and Selective Serotonin Reuptake Inhibitors in Adults With Attention-Deficit/Hyperactivity Disorder
    Lee, Dong Yun
    Kim, Chungsoo
    Shin, Yunmi
    Park, Rae Woong
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [10] Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis
    Masarwa, Reem
    Bar-Oz, Benjamin
    Gorelik, Einat
    Reif, Shimon
    Perlman, Amichai
    Matok, Ilan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : 57 - +